HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Zhao Selected Research

Phenylethyl Alcohol (Phenethyl Alcohol)

1/2020Phenylethanol Glycosides Protect Myocardial Hypertrophy Induced by Abdominal Aortic Constriction via ECE-1 Demethylation Inhibition and PI3K/PKB/eNOS Pathway Enhancement.
1/2016Phenylethanol Glycosides from Cistanche tubulosa Suppress Hepatic Stellate Cell Activation and Block the Conduction of Signaling Pathways in TGF-β1/smad as Potential Anti-Hepatic Fibrosis Agents.
12/2015Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin-induced hepatic fibrosis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Zhao Research Topics

Disease

321Neoplasms (Cancer)
12/2022 - 08/2003
112Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2022 - 11/2005
72Infections
07/2022 - 09/2002
55Neoplasm Metastasis (Metastasis)
06/2022 - 11/2004
54Lung Neoplasms (Lung Cancer)
12/2022 - 04/2007
33Carcinogenesis
11/2021 - 06/2007
29Adenocarcinoma of Lung
05/2022 - 05/2015
26Inflammation (Inflammations)
01/2022 - 06/2006
24Hepatocellular Carcinoma (Hepatoma)
01/2022 - 11/2009
24Adenocarcinoma
01/2022 - 02/2004
21Fibrosis (Cirrhosis)
04/2022 - 01/2007
21Prostatic Neoplasms (Prostate Cancer)
01/2021 - 02/2003
20COVID-19
04/2022 - 01/2020
18Stomach Neoplasms (Stomach Cancer)
01/2022 - 06/2005
16Carcinoma (Carcinomatosis)
06/2022 - 02/2004
16Colorectal Neoplasms (Colorectal Cancer)
12/2021 - 12/2003
16Pain (Aches)
10/2021 - 07/2006
15Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2007
15Breast Neoplasms (Breast Cancer)
05/2021 - 09/2009
15Schizophrenia (Dementia Praecox)
01/2021 - 11/2009
13Cognitive Dysfunction
01/2022 - 03/2014
13Hemorrhage
11/2021 - 08/2008
13Urinary Bladder Neoplasms (Bladder Cancer)
05/2020 - 08/2003
12Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 06/2015
12Disease Progression
11/2021 - 08/2003
12Renal Cell Carcinoma (Grawitz Tumor)
11/2021 - 09/2006
11Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 06/2011
11Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 03/2013
11Rectal Neoplasms (Rectal Cancer)
01/2021 - 11/2010
11Virus Diseases (Viral Diseases)
01/2021 - 11/2013
11Liver Neoplasms (Liver Cancer)
01/2021 - 11/2012
11Wounds and Injuries (Trauma)
04/2020 - 01/2013
10Necrosis
12/2022 - 01/2006
10Hypoxia (Hypoxemia)
01/2022 - 12/2012
10Lymphatic Metastasis
03/2021 - 12/2003
10Melanoma (Melanoma, Malignant)
01/2021 - 12/2007
10Liver Cirrhosis (Hepatic Cirrhosis)
12/2020 - 11/2009
10Stroke (Strokes)
11/2020 - 05/2012
9Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 01/2007
9Sarcoma (Soft Tissue Sarcoma)
11/2021 - 05/2015
9Ischemic Stroke
09/2021 - 10/2013
9Mania (Manias)
06/2015 - 11/2009
8Pneumonia (Pneumonitis)
04/2022 - 11/2011
8Mitochondrial Diseases (Mitochondrial Disease)
03/2022 - 11/2010
8Hepatitis
01/2022 - 06/2002
8Osteosarcoma (Osteogenic Sarcoma)
01/2022 - 03/2014
8Hypertension (High Blood Pressure)
11/2021 - 01/2013
8Brain Injuries (Brain Injury)
01/2021 - 07/2015
8Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2021 - 03/2009

Drug/Important Bio-Agent (IBA)

88Proteins (Proteins, Gene)FDA Link
07/2022 - 09/2002
42Biomarkers (Surrogate Marker)IBA
05/2022 - 08/2008
36MicroRNAs (MicroRNA)IBA
09/2022 - 01/2011
32ErbB Receptors (EGF Receptor)IBA
05/2022 - 12/2008
32DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2005
31Pharmaceutical PreparationsIBA
01/2022 - 08/2011
30Messenger RNA (mRNA)IBA
01/2022 - 10/2003
28Tyrosine Kinase InhibitorsIBA
04/2022 - 06/2009
26CytokinesIBA
12/2022 - 01/2007
24Biological ProductsIBA
05/2022 - 06/2002
24Long Noncoding RNAIBA
01/2022 - 07/2016
22VaccinesIBA
06/2022 - 12/2008
22RNA (Ribonucleic Acid)IBA
06/2022 - 09/2006
19Phosphotransferases (Kinase)IBA
01/2022 - 06/2009
18AntigensIBA
01/2022 - 12/2003
16Therapeutic UsesIBA
01/2022 - 06/2002
16asenapineFDA Link
06/2015 - 11/2009
15EnzymesIBA
12/2022 - 06/2006
15AntibodiesIBA
01/2022 - 08/2003
15Antiviral Agents (Antivirals)IBA
10/2021 - 08/2003
14InterferonsIBA
04/2022 - 12/2012
13Olanzapine (Zyprexa)FDA Link
07/2022 - 12/2009
13LigandsIBA
04/2022 - 11/2006
13Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 11/2004
13Interleukin-6 (Interleukin 6)IBA
12/2021 - 08/2003
13PlatinumIBA
08/2021 - 06/2008
13Small Interfering RNA (siRNA)IBA
09/2020 - 12/2007
12Immune Checkpoint InhibitorsIBA
12/2022 - 01/2018
12Peptides (Polypeptides)IBA
01/2022 - 01/2006
11Reactive Oxygen Species (Oxygen Radicals)IBA
12/2022 - 10/2011
11apatinibIBA
06/2022 - 09/2017
11Amyloid (Amyloid Fibrils)IBA
01/2022 - 09/2011
10Cisplatin (Platino)FDA LinkGeneric
07/2022 - 03/2014
10CateninsIBA
09/2021 - 10/2016
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 11/2005
9Caspase 3 (Caspase-3)IBA
12/2022 - 10/2011
9Pemetrexed (MTA)FDA Link
03/2021 - 02/2012
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 08/2003
8Indicators and Reagents (Reagents)IBA
01/2022 - 03/2012
8Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2021 - 05/2003
8Doxorubicin (Adriamycin)FDA LinkGeneric
02/2020 - 06/2011

Therapy/Procedure

136Therapeutics
07/2022 - 10/2003
87Drug Therapy (Chemotherapy)
07/2022 - 12/2006
31Radiotherapy
12/2021 - 11/2004
25Immunotherapy
12/2022 - 03/2006
11Neoadjuvant Therapy
01/2021 - 11/2010
11Lasers (Laser)
12/2020 - 06/2011
10Aftercare (After-Treatment)
05/2022 - 10/2013
9Transplantation
01/2022 - 01/2012
9Length of Stay
12/2020 - 03/2013
8Lymph Node Excision (Lymph Node Dissection)
04/2021 - 09/2013